Events

Welcome to the 8th Oncolytic Virotherapy Summit: Engineering Oncolytic Viruses Towards Revolutionary Anti-Cancer Immunotherapies Recent years have seen highly promising and rapid advances in the pre-clinical development and clinical evolution of oncolytic virotherapies. They are increasingly being recognised as a therapy with huge potential to change the landscape for cancer immunotherapy. In the past 3 months alone, we have witnessed 20 new drugs entering into pre-clinical and clinical phases, and exciting FDA Fast Track Designation for Candel Therapeutics OV candidate - this community continues to maximize the impact of these hopeful therapies. Unite with 100+ OV trailblazers across sessions spanning Early Discovery, Translation, Clinical Development, Chemistry, Manufacturing and Control…

Gene therapy developers are striving to platform their process development to more quickly and cost-effectively bring their drugs to market, meaning optimizing upstream process development has never been a greater priority for this community. The first Gene Therapy Process Development is your only specific gene therapy event with optimizing process development with the transgene at the forefront of mind. Join your biopharma colleagues from the likes of Ultragenyx, Janssen, REGENXBIO and more, for two days of cutting-edge talks on cell-line development, scale-up, transfection, purification, analytics, and regulation. This must-attend meeting is your chance to share ideas, successes, and challenges, and capitalize on the latest advances in process development to bring safe and effective drug…

Following proof of concept in oncology, misfolded and aggregated pathological proteins across CNS indications are the new frontier for protein degradation technologies. Heading to Boston, the Targeted Protein Degradation for CNS Summit is uniting 50+ experts with 3-days of industry-focused content solely dedicated to delivering and translating TPD technologies to degrade undruggable extracellular and intracellular CNS proteins. Don't miss your chance to join industry leaders pioneering the exploration of PROTACs, AUTOTACs, molecular glues, and more revolutionary TPD technologies against CNS targets. This is your only chance to attend an industry-focused meeting dedicated to showcasing early CNS biopharma investment and overcoming your challenges to translate safe and efficacious protein de…

The marcus evans 24th Edition Strategic Project & Portfolio Management for Pharma conference taking place on 17-19 January, 2024, in Frankfurt, Germany, will bring together leading project and portfolio managers to discuss how they’re supporting critical decision-making capabilities through implementing  the  best  methodologies, technologies, and organizational models. The event will explore how you can maximize the value  and  resilience  of  your  portfolio  through the  best  practices  in  project prioritization  and  resource  allocation, focusing  on  creating  the  ideal  balance  between  risks  and  opportunities. All these topics and more will be discu…

5th Edition Excellence in Real World Evidence and Data Utilization January 23- 24, 2024Philadelphia, PA The 5th Edition Excellence in Real World Evidence and Data Utilization Conference will provide insights to improve patient outcomes and treatment efficacy through the utilization of real-world data and evidence throughout the drug lifecycle.  Hear from leading industry experts from pharmaceuticals, biotech, and medical device companies with responsibilities with RWE and HEOR across diverse therapeutic expertise that address the interpretation of regulatory guidance, synthesize and model data and evidence, and determine value from the data. Key Speakers Include Charles MakinGlobal Head, HEOR, HTA & RWEBiogen Amit KulkarniHead of Health Economic Modeling a…

The eagerly anticipated mRNA-Based Therapeutics Summit Europe returns to Berlin this January for the third year as Europe's largest and most important gathering of mRNA experts. Showcasing exclusive new data from the trailblazers and thought leaders in the field, join 250+ industry specialists including the likes of the MHRA, EMA, BioNTech, CureVac, Ziphius Vaccines, Moderna and more across 3 days to uncover groundbreaking discovery, pre-clinical and clinical insights in mRNA therapeutic and vaccine development to fast-track R and D and pipeline expansions. URLs:Tickets: https://go.evvnt.com/1951095-2?pid=185Brochure: https://go.evvnt.com/1951095-3?pid=185 Prices:Conference + Focus Day OR Workshop Day - Drug Developer Pricing: EUR 4446.00,Conference Only - Drug Developer Pricing:…

The “Alpine Winter Conference on Medicinal and Synthetic Chemistry” exposes attending scientists to cutting edge synthetic and medicinal chemistry as well as latest developments in technologies that foster innovation in drug discovery. The main target audience for this highly interdisciplinary meeting will include medicinal and synthetic chemists, as well as related drug discovery disciplines from both industry and academia as well as graduate/undergraduate students and postdocs. In the spirit of Keystone and Gordon conferences as well as the MBCF (Medicinal and Bioorganic Chemistry Foundation) conference in Steamboat Springs, the format of this meeting provides ample opportunity for attendees to informally interact. The aim is to strengthen existing networks and create new contacts. The C…

This premier marcus evans conference explores future regulation implications on post market management planning, risk management, complaint handling and clinical evaluations to align with revised and ever changing EU MDR deliverables. Moreover attendees will be provide a blueprint on how to develop innovative PMCF, PSUR, safety, quality, adverse event and post market reporting document processes.

Following Merck announcing their goal to phase out animal use in their work, Astellas and MIMETAS expanding their partnership in immunotherapeutic development, and the domino effects across the field caused by the FDA Modernization Act 2.0, 2023 has set an exciting precedent for the upcoming year. However, the translation rates of oncology therapeutics into the clinic remain at 20%, proving there remains a large unmet need for tools to support drug development efforts in a patient-specific context at the preclinical and early translational levels. At the 8th Annual Tumor Models San Francisco Summit, you will gain practical insights into the latest updates across the West Coast and beyond through 25+ case studies that will empower your candidate selection workflows. Join us to learn from an…

We are delighted to welcome you to the 17th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2024) to be held on 6-9 March 2024 in Florence, Italy. We invite you to be a part of ATTD – the leading international forum – where clinicians, diabetes care providers, researchers, industries, start-up, investors, reimbursement authorities, regulators and people with diabetes, assemble with the goal to ameliorate the care of people with diabetes as the fastest possible pace. Presentations and discussions will be given by many distinguished professionals in the field and will include topics such as artificial intelligence-based decision support systems, glucose sensors, closed-loop systems, artificial pancreas, devices for diabetic prevention, new medications for…

The Annual Pharma Supply Chain & Security World Summit is back in London for the 6th time, and this time with more focus on optimizing your supply chain challenges to ensure an agile, responsive, streamlined and secured supply chain. The pharmaceutical supply chains are facing a significant challenge in the form of counterfeit drugs that are entering the supply chain from various points at different levels. Pharmaceutical companies that adopt an effective serialisation program have end-to-end visibility and traceability for all of their packaging, labelling, and distribution. This enables them to rapidly identify and quarantine counterfeit products. This helps to protect patients, consumers worldwide, brand equity, reputations and the company's revenue stream by ensuring compliance wit…

Welcome to the International Cancer Research and Drug Discovery Conference (i-Cancer Congress), in London on March 22, 2024. We're excited to bring together healthcare professionals from around the world to discuss the latest developments and innovations. i-Cancer Congress is designed to provide a platform for experts in the field of oncology to share their knowledge, exchange ideas, and collaborate on new research projects. The conference will cover a wide range of topics related to cancer research, diagnosis, treatment, and prevention. With a range of presentations, workshops, and networking opportunities, attendees will have the chance to learn from some of the most accomplished healthcare professionals in the world. In addition to learning from expert speakers, attendees will also have…

This conference will continue to focus and build on the challenges and hurdles that companies working in the microbiome space will have to recognize and navigate in order to successfully commercialize their products. Additionally, this meeting also showcases ground-breaking research being performed by leadings scientist from around the globe. Attendees will have the opportunity to hear the leading companies and academics discuss the work they have underway and how they are meeting these challenges head-on to apply recent discoveries to a variety of disease processes, restoration of health and improved outcomes. Prices:Industry: USD 1595.00,Academic/Government/Clinician: USD 695.00,Student: USD 450.00 Time: 8:00 am to 3:00 pm

Arrowhead Conferences and Event Planning is pleased to announce its 14th Annual Traumatic Brain Injury Conference will be taking place in Washington, DC on May 2-3, 2024. This conference brings together researchers and clinicians from industry, academia, the military and government to present ground-breaking research in a variety of areas related to traumatic brain injury. This event provides a special opportunity for a variety of stakeholders to present original research and analysis aimed at providing a full picture of the progress being made towards better diagnosis, treatment and long-term care for TBI survivors. At this annual event, physicians, nurses, neurosurgeons, scientists, and drug/diagnostic developers from all over the world network and learn from one another.  Focu…

Scientex Conferences warmly welcomes all the Participants, Scientists, Doctors, Nurses and Delegates from the globe to join our conference "2nd International Conference on Nursing Care and Patient Safety” on May 16-17, 2024 in Bangkok, Thailand. Nursing Care 2024 is organized around the theme "Analyzing the latest technologies and research in nursing care and patient safety " which will mark a gathering of pioneers and experts from the Medical Industry.

Following the success of the 3rd Annual Psychedelic Therapeutics and Drug Development Conference in 2023, we're thrilled to be hosting the 4th Annual event on May 23-24, 2024 in Boston, Massachusetts. This event has been organized to bring together the world's leading researchers and leaders in academia, industry, the non-profit sector and government to discuss the challenges and opportunities facing those engaged in the research and development of psychedelics for various health conditions with considerable unmet need. This event will highlight the progress being made towards regulatory approval of a variety of psychedelics with the potential to treat various conditions, including inflammatory/autoimmune disorders, brain injury, pain, PTSD, anxiety, ADHD, headaches, depression, and opioid…

Magnus Group is proud to present Chemistry 2024, a prestigious conference scheduled to be held in the beautiful city of Paris, France, from June 17-19, 2024. With the overarching theme of "Modifying Chemistry with the Novelties that Accomplish Future Goals

The International Mycological Association, together with the Dutch Mycological Society and in collaboration with the Westerdijk Fungal Biodiversity Institute, are pleased to invite you to attend the 12th International Mycological Congress (IMC12), which is going to take place on 11-15 August 2024 in Maastricht, Netherlands.The event has the mission of exploring the advancement of mycology through a range of activities focused on mycological education, training, research, and service. IMC12 will be a valuable opportunity to access the latest information in the field of mycology research while networking with fellow colleagues and enjoying the fantastic atmosphere of the city of Maastricht.